Blog · Evidence, in plain language

Exercise and depression, checked against the reviews.

Patients ask a fair version of this question at follow-up visits: if exercise helps depression, why does it sit in the wellness column while medicines get the serious conversation? Three large reviews, read together, give a better answer than either the hype or the shrug. This post walks through what they found, where they disagree, and what that means next to a medication plan.

By Karel Winner, DNP, PMHNP-BC · Published October 6, 2026

This post is education, not medical advice. It explains what researchers found about exercise and depression. It is not a reason to start, stop, or change any medicine, and it is not a personal exercise prescription. Treatment decisions belong in a conversation with your own prescriber.

Why prescribers keep bringing it up

Exercise is usually offered the way weather advice is offered: true, vague, and easy to ignore. The research behind it is more specific than the advice usually sounds. In January 2026, Cochrane published an updated review of exercise for depression. Cochrane reviews are conservative by design. The reviewers wait for randomized trials, grade how much each result can be trusted, and say so when the answer is weak. Their update is a useful anchor for a medication practice, because it compares exercise head to head with the two treatments this practice provides: therapy and antidepressant medicines.

What the Cochrane update found

The update covered 73 randomized trials with 4,985 adults with depression, adding 35 trials to the previous version. Against no treatment or a comparison activity, exercise produced a moderate reduction in depression symptoms, and the reviewers rated that evidence low certainty, which means the true effect could differ from the estimate. Against psychological therapy, in 10 trials, there was little to no difference in symptom reduction, and that evidence was rated moderate certainty. Against antidepressant medicines, in 5 trials, there was also little to no difference, rated low certainty. Very few trials followed people after the programs ended, so whether the benefit lasts is genuinely unknown.

Two details are worth knowing. Programs that totaled between 13 and 36 sessions were linked to larger improvements, and mixed programs and resistance training looked stronger than aerobic exercise alone in this review. Unwanted effects from exercise were uncommon and were mostly aches and joint or muscle injuries in a small number of participants.

What the two larger reviews add

A 2024 analysis in The BMJ pooled 218 studies with 14,170 people who met clinical cut-offs for major depression. Walking or jogging, yoga, and strength training showed the largest reductions in symptoms, ahead of mixed aerobic exercise and tai chi or qigong. An umbrella review in the British Journal of Sports Medicine went one level up and combined 97 earlier reviews, covering 1,039 trials and 128,119 participants. It found medium-sized improvements in depression, anxiety, and psychological distress, with the largest benefits in people with depression. Three different teams, working at three different scales, land in the same place: the effect is real, and it is moderate, not miraculous.

Where the reviews disagree, stated plainly

They disagree about intensity. The BMJ analysis and the umbrella review both found that harder exercise was linked to larger improvements. The Cochrane update found the opposite pattern, with light to moderate intensity looking better than vigorous exercise. All three reviews also carry quality warnings. In the BMJ analysis, only one study met the strict criteria for low risk of bias, and the authors rated their confidence low for walking or jogging and very low for the other forms. In the umbrella review, 77 of the 97 reviews it combined were rated critically low quality. The honest summary is that exercise helps depression on average, the size of the help is uncertain, and nobody can yet say which kind or how hard is best for a given person.

What this means next to a medication plan

Nothing in these reviews is an argument for stopping a medicine that is working, or for delaying one that is needed. The comparisons with antidepressants rest on a handful of small trials, which is not a base for trading a treatment with known effects for a program whose long-term effects are unmeasured. Where exercise earns its place in a medication plan is alongside: it is one of the few additions with trial evidence behind it, it supports sleep and general health at the same time, and a change in activity is useful information at a follow-up visit, because a patient who has stopped moving entirely is often telling you the depression is winning before the rating scale shows it.

If you and your prescriber decide to build activity into your plan, the trial programs were structured and repeated, not occasional. That is the part worth copying: a scheduled activity you can actually sustain counts for more than an ambitious program abandoned in week two. Bring it up at your visit rather than quietly substituting it for a dose.

The bottom line

The best current evidence says exercise reduces depression symptoms by a moderate amount, performs about the same as therapy in the small number of direct comparisons, and has not been tested well enough against medicines to justify swapping one for the other. Prescribers who mention it are not changing the subject. They are using one of the better-studied tools that sits next to medication, and the follow-up visit is where it gets fitted to your history, your health, and your life.

Sources

This post is based on the sources below. The numbers quoted are the reviews' own numbers.

Clegg and colleagues, Cochrane Database of Systematic Reviews (January 2026): an updated review of exercise for depression, 73 randomized trials with 4,985 participants, adding 35 trials to the previous version. Cochrane Library.

Noetel and colleagues, The BMJ (2024): a systematic review and network meta-analysis of exercise for major depression, 218 studies with 14,170 participants. The BMJ.

Singh and colleagues, British Journal of Sports Medicine (2023): an umbrella review of physical activity and symptoms of depression, anxiety, and distress, covering 97 reviews, 1,039 trials, and 128,119 participants. PubMed record.

Please read this part

Nothing in this post is medical advice, and reading it does not create a treatment relationship. The studies below describe averages across large groups. They cannot predict what exercise, or any medicine, will do for you. If you take a psychiatric medicine, do not change it because of an exercise headline in either direction. If you have a heart condition, joint problems, an eating disorder history, or any condition that limits activity, talk with your clinician before changing how much you exercise.

If you are having thoughts of harming yourself, help is available now: call or text 988, text HOME to 741741 for Crisis Text Line, or call the NAMI Helpline at 1-800-950-6264. This practice is not an emergency service. If someone is in immediate danger, call 911. The crisis page lists more options.

“A medication that has done its job deserves a careful goodbye, planned like the treatment it was.”

Plan the goodbye: deprescribing, as a service